Heeley Emma, Waller Patrick, Moseley Jane
Post-Licensing Division, Medicines and Healthcare products Regulatory Agency, London, UK.
Drug Saf. 2005;28(10):901-6. doi: 10.2165/00002018-200528100-00006.
Statistical signal detection methods such as proportional reporting ratios (PRRs) detect many drug safety signals when applied to databases of spontaneous suspected adverse drug reactions (ADRs). Impact analysis is a tool that was developed as an aid to prioritisation of such signals. This paper describes a pilot project whereby impact analysis was simultaneously introduced into practice in a regulatory setting and tested in comparison with the existing approach.
Impact analysis was run on signals detected during a 26-week period from the UK Adverse Drug Reactions On-line Information Tracking (ADROIT) database of spontaneous ADRs that met minimum criteria (PRR>or=3.0, chi2>or=4.0 and >or=3 reported cases) and related to established drugs (i.e. those that have been available for at least 2 years and no longer carry the 'black triangle' symbol). The current method of signal prioritisation (i.e. the collective judgement at a weekly meeting) was initially performed without knowledge of the findings of impact analysis. Subsequently, the meeting was presented with the findings and, where appropriate, given the opportunity to reconsider the judgement made. The categories arising from the two methods were compared and the ultimate action recorded. Inter-observer variation between scientists performing impact analysis was also assessed.
Eighty-six separate signals were analysed by impact analysis, of which 5% were categorised as high priority (A), 14% as requiring further information (B), 31% as low priority (C) and 50% as no action required (D). In general, the new method tended to give a higher level of priority to signals than the existing approach. Overall, there was 59% agreement between the impact analysis and the collective judgement at the meetings (kappa statistic=0.30). There was slightly greater agreement between impact analysis and the final action taken (kappa statistic=0.39), indicating that the findings of an impact analysis had an influence on the outcome. Assessment of inter-observer variation demonstrated that the method is repeatable (kappa statistic for overall category=0.77). Almost 70% of those who participated in the pilot study believed that impact analysis represented an improvement in how signals were prioritised.
Impact analysis is a repeatable method of signal prioritisation that tended to give a higher level of priority to signals than the standard approach and which had an influence on the ultimate outcome.
诸如比例报告比(PRRs)等统计信号检测方法应用于自发疑似药物不良反应(ADR)数据库时,能检测出许多药物安全信号。影响分析是一种为帮助对此类信号进行优先级排序而开发的工具。本文描述了一个试点项目,在该项目中,影响分析在监管环境中被同时引入实践,并与现有方法进行比较测试。
对从英国药物不良反应在线信息跟踪(ADROIT)自发ADR数据库中在26周期间检测到的信号进行影响分析,这些信号符合最低标准(PRR≥3.0、卡方检验≥4.0且报告病例数≥3),并且与已上市药物相关(即那些已上市至少两年且不再带有“黑三角”标志的药物)。信号优先级排序的当前方法(即每周会议上的集体判断)最初在不了解影响分析结果的情况下进行。随后,向会议展示结果,并在适当情况下让其有机会重新考虑做出的判断。比较两种方法产生的类别,并记录最终行动。还评估了进行影响分析的科学家之间的观察者间差异。
通过影响分析对86个单独的信号进行了分析,其中5%被归类为高优先级(A),14%为需要进一步信息(B),31%为低优先级(C),50%为无需采取行动(D)。总体而言,新方法往往比现有方法赋予信号更高的优先级。总体而言,影响分析与会议上的集体判断之间有59%的一致性(卡方统计量=0.30)。影响分析与最终采取的行动之间的一致性略高(卡方统计量=0.39),表明影响分析的结果对结果有影响。观察者间差异评估表明该方法具有可重复性(总体类别的卡方统计量=0.77)。参与试点研究的人中近70%认为影响分析代表了信号优先级排序方式的改进。
影响分析是一种可重复的信号优先级排序方法,它往往比标准方法赋予信号更高的优先级,并且对最终结果有影响。